Primex News International

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    TAKE Solutions Delivers Strong Financial Performance for FY26 with Rs 6,087 Lakhs Consolidated Total Income, registering a robust 495.68% Y-o-Y Growth

    May 25, 2026

    Lehar Footwears Delivers Breakout FY26 Performance; Revenue Surges 55 Percent, Profit Soars -92 Percent YoY

    May 25, 2026

    Dr Vivek Bindra’s Bada Business Investee Company Branded Factory Launches Mega Retail Outlet in Vadodara

    May 25, 2026
    Facebook Twitter Instagram
    Primex News International
    • Home
    Facebook Twitter Instagram
    Primex News International
    Home»Business»Moxesh Zota, Carving a niche in the pharma industry
    Business

    Moxesh Zota, Carving a niche in the pharma industry

    By April 23, 2024No Comments3 Mins Read
    Facebook Twitter Pinterest Telegram LinkedIn Tumblr WhatsApp Email
    Share
    Facebook Twitter LinkedIn Pinterest Telegram Email

    Moxesh Zota, the Managing Director of Surat-based Zota Healthcare Limited, a company offering a vast range of pharmaceutical, nutraceutical, and Ayurvedic medicines, has carved a niche in the pharma industry with his leadership and dedication to expanding access to quality healthcare.

    Mr Zota, 33, is a young entrepreneur who has been instrumental in driving the growth and success of the company over the past eight years. With a Bachelor of Pharmacy degree from Gujarat Technological University and an MBA in International Marketing and Business Management from BPP University, UK, he brings a unique blend of technical expertise and business acumen to his role. Under his stewardship, Zota Healthcare has made significant strides and established a global presence with footprints in 30+ countries and offices in India, Sri Lanka, Vietnam, and Nigeria.

    His strategic vision has been key to expanding Zota Healthcare’s product portfolio and securing registrations for over 200 products in various foreign markets, and an additional 150 products currently under registration. He oversees all aspects of the company’s management, export business, and strategic planning for new project implementation. Mr Zota’s humbleness & desire to learn new things in life will make him into a promising future leader. 

    NSE-listed Zota Healthcare has garnered widespread recognition for its commitment to providing affordable and high-quality medicines to patients. The company’s diverse range of pharmaceutical, nutraceutical, and Ayurvedic products reflects its dedication to meeting the healthcare needs of diverse populations.

    “As a pharmaceutical company, our mission is to make a positive impact on people’s lives by providing affordable and high-quality medicines. We are committed to delivering unparalleled healthcare solutions globally and will continue to innovate and expand our reach to all corners of the globe to improve the health and well-being of people around the world,” says Mr Zota.

    One of the most path breaking initiatives of Zota Healthcare ltd in India has been Davaindia. Davaindia is India’s largest chain of Retail generic pharmacies that has revolutionized the Indian Healthcare landscape by providing high quality generic medicines at affordable costs and this initiative has been acknowledged on multiple public & private forums like Times Icon, BARC Asia, Indian glory etc. Within a short span of time, Davaindia’s generic medicines being dispensed from 700 + outlets across India are ensuring that every Indian has a strip of Generic medicine in their pockets.

    Under Mr Zota’s guidance, Zota Healthcare has been increasingly emphasizing research and development, driving innovation and ensuring the efficacy of its pharmaceutical formulations. The company is poised for continued growth and success as it strives to improve access to essential medicines and promote better health outcomes for all.

    Business
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Related Posts

    TAKE Solutions Delivers Strong Financial Performance for FY26 with Rs 6,087 Lakhs Consolidated Total Income, registering a robust 495.68% Y-o-Y Growth

    May 25, 2026

    Lehar Footwears Delivers Breakout FY26 Performance; Revenue Surges 55 Percent, Profit Soars -92 Percent YoY

    May 25, 2026

    Dr Vivek Bindra’s Bada Business Investee Company Branded Factory Launches Mega Retail Outlet in Vadodara

    May 25, 2026

    Soil Data. Crop Stage. Disease Risk. Weather Forecast. Inside the Proprietary ML Stack That Powers Every Farmneed Farm Advisory

    May 25, 2026

    What Precision Agriculture Really Costs for Small and Marginal Farmers: A Look Through Sat2Farm

    May 25, 2026

    The Fern Vishranta, Kamrej, Sets a New Standard for Luxury Hospitality Between Mumbai and Ahmedabad

    May 25, 2026

    Comments are closed.

    Top Reviews
    Editors Picks

    TAKE Solutions Delivers Strong Financial Performance for FY26 with Rs 6,087 Lakhs Consolidated Total Income, registering a robust 495.68% Y-o-Y Growth

    May 25, 2026

    Lehar Footwears Delivers Breakout FY26 Performance; Revenue Surges 55 Percent, Profit Soars -92 Percent YoY

    May 25, 2026

    Dr Vivek Bindra’s Bada Business Investee Company Branded Factory Launches Mega Retail Outlet in Vadodara

    May 25, 2026

    PW Skills Launches PW Skillshala: A Network of Offline Upskilling Centres Across India

    May 25, 2026
    About Us
    About Us
    Our Picks

    TAKE Solutions Delivers Strong Financial Performance for FY26 with Rs 6,087 Lakhs Consolidated Total Income, registering a robust 495.68% Y-o-Y Growth

    May 25, 2026

    Lehar Footwears Delivers Breakout FY26 Performance; Revenue Surges 55 Percent, Profit Soars -92 Percent YoY

    May 25, 2026

    Dr Vivek Bindra’s Bada Business Investee Company Branded Factory Launches Mega Retail Outlet in Vadodara

    May 25, 2026
    Top Reviews
    © 2026 Primex News International. Designed by Primex Media Services.
    • Home

    Type above and press Enter to search. Press Esc to cancel.